These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 12198876)

  • 21. Accuracy of pathologic examination in detection of complete response after chemoradiation for esophageal cancer.
    Chang EY; Smith CA; Corless CL; Thomas CR; Hunter JG; Jobe BA
    Am J Surg; 2007 May; 193(5):614-7; discussion 617. PubMed ID: 17434367
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preoperative radiotherapy combined with resection of squamous cell carcinoma of the mid-thoracic oesophagus. Does a histopathological malignancy grading system assess actual survival?
    Lewiński T; Morysiński T; Pietrow D; Sikora K
    Eur J Surg Oncol; 1991 Dec; 17(6):571-4. PubMed ID: 1743305
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The clinical impact of histopathologic response assessment by residual tumor cell quantification in esophageal squamous cell carcinomas.
    Brücher BL; Becker K; Lordick F; Fink U; Sarbia M; Stein H; Busch R; Zimmermann F; Molls M; Höfler H; Siewert JR
    Cancer; 2006 May; 106(10):2119-27. PubMed ID: 16607651
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Esophagogastric cancer--time to change the paradigm.
    O'Sullivan GC; Shanahan F
    Am J Gastroenterol; 2000 Sep; 95(9):2153-4. PubMed ID: 11007209
    [No Abstract]   [Full Text] [Related]  

  • 25. Endosonographic assessment of multimodality therapy predicts survival of oesophageal carcinoma patients.
    Eloubeidi MA; Wallace MB
    Gastrointest Endosc; 2001 Jul; 54(1):132-4. PubMed ID: 11447984
    [No Abstract]   [Full Text] [Related]  

  • 26. Patients with locally advanced esophageal carcinoma nonresponder to radiochemotherapy: who will benefit from surgery?
    Piessen G; Briez N; Triboulet JP; Mariette C
    Ann Surg Oncol; 2007 Jul; 14(7):2036-44. PubMed ID: 17453293
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cancer of the esophagus in Acadiana.
    Rainey JM; Harwood AR; Crouch M
    J La State Med Soc; 1994 Apr; 146(4):159-61. PubMed ID: 8006499
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of carcinoma of the esophagus.
    Seibert DG; Hill RC
    W V Med J; 1989 Feb; 85(2):53-7. PubMed ID: 2464245
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Combined radiochemotherapy in treatment of esophageal cancers].
    Bosset JF; Gignoux M; Mantion G; Heyd B; Salame E; Queneau PE; Lorchel F
    Ann Chir; 1998; 52(2):185-91. PubMed ID: 9752439
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic significance of vascular endothelial growth factor and cyclooxygenase 2 expression in patients receiving preoperative chemoradiation for esophageal cancer.
    Kulke MH; Odze RD; Mueller JD; Wang H; Redston M; Bertagnolli MM
    J Thorac Cardiovasc Surg; 2004 Jun; 127(6):1579-86. PubMed ID: 15173710
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endoscopic therapy of esophago-gastric tumors.
    Lambert R
    Endoscopy; 1992; 24(1-2):24-33. PubMed ID: 1373114
    [No Abstract]   [Full Text] [Related]  

  • 32. Refining esophageal cancer staging after neoadjuvant therapy: importance of treatment response.
    Barbour AP; Jones M; Gonen M; Gotley DC; Thomas J; Thomson DB; Burmeister B; Smithers BM
    Ann Surg Oncol; 2008 Oct; 15(10):2894-902. PubMed ID: 18663531
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Excellent interobserver agreement on grading the extent of residual carcinoma after preoperative chemoradiation in esophageal and esophagogastric junction carcinoma: a reliable predictor for patient outcome.
    Wu TT; Chirieac LR; Abraham SC; Krasinskas AM; Wang H; Rashid A; Correa AM; Hofstetter WL; Ajani JA; Swisher SG
    Am J Surg Pathol; 2007 Jan; 31(1):58-64. PubMed ID: 17197919
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term results of a phase II trial of neoadjuvant chemotherapy followed by esophagectomy for locally advanced esophageal neoplasm.
    Pennathur A; Luketich JD; Landreneau RJ; Ward J; Christie NA; Gibson MK; Schuchert M; Cooper K; Land SR; Belani CP
    Ann Thorac Surg; 2008 Jun; 85(6):1930-6; discussion 1936-7. PubMed ID: 18498797
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors affecting postoperative course and survival after en bloc resection for esophageal carcinoma.
    Mariette C; Taillier G; Van Seuningen I; Triboulet JP
    Ann Thorac Surg; 2004 Oct; 78(4):1177-83. PubMed ID: 15464466
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of HLA-G is associated with prognosis in esophageal squamous cell carcinoma.
    Yie SM; Yang H; Ye SR; Li K; Dong DD; Lin XM
    Am J Clin Pathol; 2007 Dec; 128(6):1002-9. PubMed ID: 18024326
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Survival after esophageal resection for carcinoma: the importance of the histologic cell type.
    Alexiou C; Khan OA; Black E; Field ML; Onyeaka P; Beggs L; Duffy JP; Beggs DF
    Ann Thorac Surg; 2006 Sep; 82(3):1073-7. PubMed ID: 16928541
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multi-modality treatment in oesophageal cancer: a curse for radiotherapy progress.
    Tait DM
    Radiother Oncol; 2004 Nov; 73(2):115-7. PubMed ID: 15542157
    [No Abstract]   [Full Text] [Related]  

  • 39. [Surgical therapy for esophageal carcinoma: a prospective 20-year analysis].
    Gockel I; Sultanov FS; Domeyer M; Trinh TT; Gönner U; Junginger T
    Zentralbl Chir; 2008 Jun; 133(3):260-6. PubMed ID: 18563693
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical trials for esophageal carcinoma.
    Miller DL
    Chest Surg Clin N Am; 2000 Aug; 10(3):583-90. PubMed ID: 10967759
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.